Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

306 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine among adults aged ≥65 years: recommendations of the Advisory Committee on Immunization Practices (ACIP).
Tomczyk S, Bennett NM, Stoecker C, Gierke R, Moore MR, Whitney CG, Hadler S, Pilishvili T; Centers for Disease Control and Prevention (CDC). Tomczyk S, et al. Among authors: whitney cg. MMWR Morb Mortal Wkly Rep. 2014 Sep 19;63(37):822-5. MMWR Morb Mortal Wkly Rep. 2014. PMID: 25233284 Free PMC article.
Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine.
Whitney CG, Farley MM, Hadler J, Harrison LH, Bennett NM, Lynfield R, Reingold A, Cieslak PR, Pilishvili T, Jackson D, Facklam RR, Jorgensen JH, Schuchat A; Active Bacterial Core Surveillance of the Emerging Infections Program Network. Whitney CG, et al. N Engl J Med. 2003 May 1;348(18):1737-46. doi: 10.1056/NEJMoa022823. N Engl J Med. 2003. PMID: 12724479 Free article.
Changing epidemiology of invasive pneumococcal disease among older adults in the era of pediatric pneumococcal conjugate vaccine.
Lexau CA, Lynfield R, Danila R, Pilishvili T, Facklam R, Farley MM, Harrison LH, Schaffner W, Reingold A, Bennett NM, Hadler J, Cieslak PR, Whitney CG; Active Bacterial Core Surveillance Team. Lexau CA, et al. Among authors: whitney cg. JAMA. 2005 Oct 26;294(16):2043-51. doi: 10.1001/jama.294.16.2043. JAMA. 2005. PMID: 16249418
Effect of introduction of the pneumococcal conjugate vaccine on drug-resistant Streptococcus pneumoniae.
Kyaw MH, Lynfield R, Schaffner W, Craig AS, Hadler J, Reingold A, Thomas AR, Harrison LH, Bennett NM, Farley MM, Facklam RR, Jorgensen JH, Besser J, Zell ER, Schuchat A, Whitney CG; Active Bacterial Core Surveillance of the Emerging Infections Program Network. Kyaw MH, et al. Among authors: whitney cg. N Engl J Med. 2006 Apr 6;354(14):1455-63. doi: 10.1056/NEJMoa051642. N Engl J Med. 2006. PMID: 16598044 Free article.
Preventability of invasive pneumococcal disease and assessment of current polysaccharide vaccine recommendations for adults: United States, 2001-2003.
Greene CM, Kyaw MH, Ray SM, Schaffner W, Lynfield R, Barrett NL, Long C, Gershman K, Pilishvili T, Roberson A, Zell ER, Whitney CG, Bennett NM; Active Bacterial Core Surveillance Program of the Emerging Infections Program Network. Greene CM, et al. Among authors: whitney cg. Clin Infect Dis. 2006 Jul 15;43(2):141-50. doi: 10.1086/505117. Epub 2006 Jun 9. Clin Infect Dis. 2006. PMID: 16779739
Adults with invasive pneumococcal disease: missed opportunities for vaccination.
Kyaw MH, Greene CM, Schaffner W, Ray SM, Shapiro M, Barrett NL, Gershman K, Craig AS, Roberson A, Zell ER, Schuchat A, Bennett NM, Whitney CG; Active Bacterial Core Surveillance Program of the Emerging Infections Program Network. Kyaw MH, et al. Among authors: whitney cg. Am J Prev Med. 2006 Oct;31(4):286-92. doi: 10.1016/j.amepre.2006.06.007. Epub 2006 Aug 22. Am J Prev Med. 2006. PMID: 16979452
306 results